Press release
Deadline on Sept. 20th coming up in Lawsuit for Investors in CorMedix Inc. (NASDAQ: CRMD)
A Deadline is coming up on September 20, 2021 in the lawsuit for certain investors in CorMedix Inc. (NASDAQ: CRMD).
Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and there are strict and short deadlines running. Deadline: September 20, 2021. NASDAQ: CRMD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of CorMedix Inc. (NASDAQ: CRMD) common shares between July 8, 2020 and May 13, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between July 8, 2020 and May 13, 2021, the Defendants made material misrepresentations concerning the following: (i) deficiencies existed with respect to DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) in light of the foregoing deficiencies, the FDA was unlikely to approve the DefenCath NDA for CRBSIs in its present form; (iii) Defendants had downplayed the true scope of the deficiencies with DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Sept. 20th coming up in Lawsuit for Investors in CorMedix Inc. (NASDAQ: CRMD) here
News-ID: 2384962 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders…
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) sho …
An investor, who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS), filed a lawsuit over alleged violations of Federal Securities Laws by AST SpaceMobile, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 17, 2024. NASDAQ: ASTS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDA …
An investor, who purchased shares of Sharecare, Inc. (NASDAQ: SHCR), filed a lawsuit over alleged violations of Federal Securities Laws by Sharecare, Inc.
Investors who purchased shares of Sharecare, Inc. (NASDAQ: SHCR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2024. NASDAQ: SHCR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Atlanta, GA based Sharecare, Inc. operates as…
More Releases for CorMedix
NASDAQ: CRMD Investor Notice: Update in Lawsuit against CorMedix Inc. announced
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of CorMedix Inc. (NASDAQ: CRMD).
Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On July 22, 2021, a lawsuit was filed against CorMedix Inc. over alleged Securities Laws Violations. The plaintiff claimed that between July 8, 2020…
Catheter Related Blood Stream Infection Market to see Business Opportunities 202 …
📝Global Catheter Related Blood Stream Infection Market 2022-2028, by Drug Class (Non-antibiotic, Anti-infective, and Antimicrobial),By Pathogenesis (Contaminated Catheter Hub ,Contaminated Infusate ,Skin Insertion ,Hematogenous )By Source of Infection/Micro-organisms ( Staph. Aureus , P.aeruginsa ,CONS ,Aciento.Baumanii ,E.coli ,K. pnemoniae, Candida sp.) by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and…
Catheter Related Blood Stream Infection Market to Witness Robust Expansion Throu …
Global "Catheter Related Blood Stream Infection Market" 2022 contains the investigation of significant worth and volume patterns and evaluating history. Development initiating perspectives, Market restrictions, and ongoing advancements have additionally been examined in the report so as to give further learning about the business. This report spreads key development drivers and difficulties for Catheter Related Blood Stream Infection Market. On a provincial premise, the report looks at the market in…
Catheter Related Blood Stream Infection Market Overall Study Report 2021-2028 | …
The report examines the Catheter Related Blood Stream Infection request with respect to the assiduity trends, growth rate, prospects, motorists, conditions, pitfalls, and economic openings, by means of distinguishing the high- growth parts of the request through the colorful stakeholders. The statistical surveying study also elucidates the different strategies, collaborations, junction and accessions, product launches, inventions, and the conditioning in the R&D sector in the Catheter Related Blood Stream Infection…
Investigation announced for Investors in NASDAQ: CRMD shares over potential Wron …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of CorMedix Inc..
Investors who are current long term investors in CorMedix Inc. (NASDAQ: CRMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: CRMD stocks follows a lawsuit filed against CorMedix Inc. over…
Lawsuit filed for Investors in shares of CorMedix Inc. (NASDAQ: CRMD)
An investor, who purchased shares of CorMedix Inc. (NASDAQ: CRMD), filed a lawsuit i over alleged violations of Federal Securities Laws by CorMedix Inc.
Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and for certain investors are short and strict deadlines running. Deadline: September 20, 2021. NASDAQ: CRMD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Berkeley Heights, NJ based CorMedix Inc.,…
